Latest Articles

Publication Date
All News Scientific
Pete Davidson ‘confused’ by Elsie Hewitt’s claims that she is raising their baby alone — but pals reveal why this isn’t like his past break-ups - Page Six

Pete Davidson ‘confused’ by Elsie Hewitt’s claims that she is raising their baby alone — but pals reveal why this isn’t like his past break-ups Page Six

Published: May 23, 2026, 3 p.m.
Read Full Article
Pete Davidson ‘confused’ by Elsie Hewitt’s claims that she is raising their baby alone - Page Six

Pete Davidson ‘confused’ by Elsie Hewitt’s claims that she is raising their baby alone Page Six

Published: May 23, 2026, 3 p.m.
Read Full Article
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance

Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance

Published: May 23, 2026, 12:01 p.m.
Read Full Article
Barbara Palvin and Dylan Sprouse announce pregnancy at Cannes Film Festival - MSN

Barbara Palvin and Dylan Sprouse announce pregnancy at Cannes Film Festival MSN

Published: May 22, 2026, 3:05 a.m.
Read Full Article
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results - Yahoo Finance

How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results Yahoo Finance

Published: May 20, 2026, 6:22 p.m.
Read Full Article
Dylan Sprouse, Barbara Palvin expecting first child - MSN

Dylan Sprouse, Barbara Palvin expecting first child MSN

Published: May 20, 2026, 12:48 p.m.
Read Full Article
Dylan Sprouse and Barbara Palvin Expecting Their First Child Together - Yahoo

Dylan Sprouse and Barbara Palvin Expecting Their First Child Together Yahoo

Published: May 19, 2026, 10:34 p.m.
Read Full Article
Barbara Palvin and Dylan Sprouse reveal pregnancy at Cannes - MSN

Barbara Palvin and Dylan Sprouse reveal pregnancy at Cannes MSN

Published: May 19, 2026, 2:58 p.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!